Showing results (521-530 of 900) with videos related to

Sort By:
Pageof 90
Journal of Atrial Fibrillation|December 24, 2021
Temperature-Controlled Catheter Ablation for Paroxysmal Atrial Fibrillation: the QDOT-MICRO Workflow SttudyTom De Potter, Massimo Grimaldi, Henrik Kjaerulf Jensen, et al.
Cell Death and Differentiation|May 23, 2018
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2Sona Hubackova, Eliska Davidova, Katerina Rohlenova, et al.
Vaccine|April 24, 2012
Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and AsiaKristen D C Lewis, Michael J Dallas, John C Victor, et al.
International Journal of Epidemiology|December 22, 2005
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniorsLisa A Jackson, Jennifer C Nelson, Patti Benson, et al.
Oncogene|March 9, 2021
SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagyZuzana Ezrova, Zuzana Nahacka, Jan Stursa, et al.
Journal of Cardiovascular Electrophysiology|November 23, 2007
Catheter ablation of peri-AV nodal atrial tachycardia from the noncoronary cusp of the aortic valveSaumya Das, Petr Neuzil, Christine M Albert, et al.
Redox Report : Communications in Free Radical Research|November 15, 2013
Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacyJaromira Kovarova, Martina Bajzikova, Magdalena Vondrusova, et al.
Heart Rhythm|July 29, 2014
Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring deviceMarc A Miller, Sandeep R Gangireddy, Shephal K Doshi, et al.
Emerging Infectious Diseases|April 21, 2020
Effects of Air Pollution and Other Environmental Exposures on Estimates of Severe Influenza Illness, Washington, USARanjani Somayaji, Moni B Neradilek, Adam A Szpiro, et al.
Vaccine|April 24, 2012
Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infantsKayla F Laserson, Daveline Nyakundi, Daniel R Feikin, et al.
Pageof 90